(taken from the application) We have previously described the consequences of targeted over-expression of parathyroid hormone-related protein (PTHrP) in the pancreatic islet of transgenic mice using the rat insulin-II (RIP) promoter. These observations have focused the applicant's attention on transgenic approaches to defining the factors to the islet use using viral gene delivery strategies. With this background, we have recently prepared two additional lines of RIP-promoter targeted transgenic mice. One, the RIP- mPL-1 mouse, takes advantage of the observation that murine placental lactogen-1 (mPL-1) appears to participate in islet mass augmentation during pregnancy, and is able to increase islet proliferation rates in vitro. The second, the RIP-HGH mouse, starts with the premise that hepatocyte growth factor (HGF) appears to play a role in fetal islet development, and is able to stimulate islet proliferation in vitro. The RIP-HGF founders have very recently been prepared and can transmit the transgene, but have not yet been further characterized. The RIP-mPL-1 mice have been preliminary characterized, and are hypoglycemic, have an increase in islet mass, and an increase in islet proliferation rates. This proposal has three Specific Aims: 1. To further characterize the consequences of targeted over-expression of mPL-1 in the islet of the RIP-mPL-1 mouse. 2. To define the consequences of targeted over-expression of HGF in the islet in the RIP-HGF mouse. 3. To explore the therapeutic potential for viral gene delivery of PTHrP, mPL-1, and HGF in the pancreatic islet.
| Puri, Sapna; Roy, Nilotpal; Russ, Holger A et al. (2018) Replication confers ? cell immaturity. Nat Commun 9:485 |
| Karakose, Esra; Ackeifi, Courtney; Wang, Peng et al. (2018) Advances in drug discovery for human beta cell regeneration. Diabetologia : |
| Chen, Hainan; Kleinberger, Jeffrey W; Takane, Karen K et al. (2015) Augmented Stat5 Signaling Bypasses Multiple Impediments to Lactogen-Mediated Proliferation in Human ?-Cells. Diabetes 64:3784-97 |
| Wang, Peng; Alvarez-Perez, Juan-Carlos; Felsenfeld, Dan P et al. (2015) A high-throughput chemical screen reveals that harmine-mediated inhibition of DYRK1A increases human pancreatic beta cell replication. Nat Med 21:383-8 |
| Wang, Peng; Fiaschi-Taesch, Nathalie M; Vasavada, Rupangi C et al. (2015) Diabetes mellitus--advances and challenges in human ?-cell proliferation. Nat Rev Endocrinol 11:201-12 |
| Stewart, Andrew F; Hussain, Mehboob A; García-Ocaña, Adolfo et al. (2015) Human ?-cell proliferation and intracellular signaling: part 3. Diabetes 64:1872-85 |
| Stewart, Andrew F (2014) Betatrophin versus bitter-trophin and the elephant in the room: time for a new normal in ?-cell regeneration research. Diabetes 63:1198-9 |
| Bernal-Mizrachi, Ernesto; Kulkarni, Rohit N; Scott, Donald K et al. (2014) Human ?-cell proliferation and intracellular signaling part 2: still driving in the dark without a road map. Diabetes 63:819-31 |
| Bender, Aaron; Stewart, Andrew F (2014) Good news for the ageing beta cell. Diabetologia 57:265-9 |
| García-Ocaña, Adolfo; Stewart, Andrew F (2014) ""RAS""ling ? cells to proliferate for diabetes: why do we need MEN? J Clin Invest 124:3698-700 |
Showing the most recent 10 out of 28 publications
